Evidence map›Paper›PMID 24145676›Full record

ArticleThe American journal of gastroenterology2013

Opium use and risk of mortality from digestive diseases: a prospective cohort study.

Masoud M Malekzadeh, Hooman Khademi, Akram Pourshams, Arash Etemadi, Hossein Poustchi, Mohammad Bagheri, Masoud Khoshnia, Amir Ali Sohrabpour, Ali Aliasgari, Elham Jafari and 9 more

Abstract read
In one paragraph

Article in The American journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Opium Usage and Risk of Head and Neck Cancer: A Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2021
    Pooled it
  2. Article
  3. Associations between Opium Route of Use and Exposure to Polycyclic Aromatic Hydrocarbons as Potential Carcinogenicity Mechanism.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Opioid Modulation of the Gut-Brain Axis in Opioid-Associated Comorbidities.Cold Spring Harbor perspectives in medicine · 2021
    Review
  12. Article
  13. Article
  14. Observational
  15. Opium and risk of gastrointestinal cancer: a case-control studyTurkish journal of medical sciences · 2020
    Article
  16. Article
  17. Opiate and Tobacco Use and Exposure to Carcinogens and Toxicants in the Golestan Cohort Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  18. Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.Clinical and experimental gastroenterology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Masoud M Malekzadeh1] Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran [2] These authors contributed equally to this work.
Hooman Khademi
Akram Pourshams
Arash Etemadi
Hossein Poustchi
Mohammad Bagheri
Masoud Khoshnia
Amir Ali Sohrabpour
Ali Aliasgari
Elham Jafari
Farhad Islami
Shahryar Semnani
Christian C Abnet
Paul D P Pharoah
Paul Brennan
Paolo Boffetta
Sanford M Dawsey
Reza Malekzadeh
Farin Kamangar

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
Cancer Research UK C20/A5860Intramural NIH HHS ZIA CP000185
6 · The paper itself

Abstract

objectivesOpium use, particularly in low doses, is a common practice among adults in northeastern Iran. We aimed to investigate the association between opium use and subsequent mortality from disorders of the digestive tract.

methodsWe used data from the Golestan Cohort Study, a prospective cohort study in northeastern Iran, with detailed, validated data on opium use and several other exposures. A total of 50,045 adults were enrolled during a 4-year period (2004-2008) and followed annually until December 2012, with a follow-up success rate of 99%. We used Cox proportional hazard regression models to evaluate the association between opium use and outcomes of interest.

resultsIn all, 8,487 (17%) participants reported opium use, with a mean duration of 12.7 years. During the follow-up period 474 deaths from digestive diseases were reported (387 due to gastrointestinal cancers and 87 due to nonmalignant etiologies). Opium use was associated with an increased risk of death from any digestive disease (adjusted hazard ratio (HR)=1.55, 95% confidence interval (CI)=1.24-1.93). The association was dose dependent, with a HR of 2.21 (1.57-3.31) for the highest quintile of cumulative opium use vs. no use (Ptrend=0.037). The HRs (95% CI) for the associations between opium use and malignant and nonmalignant causes of digestive mortality were 1.38 (1.07-1.76) and 2.60 (1.57-4.31), respectively. Increased risks were seen both for smoking opium and for ingestion of opium.

conclusionsLong-term opium use, even in low doses, is associated with increased risk of death from both malignant and nonmalignant digestive diseases.

Indexed as

Drug UsersAdultAgedCohort StudiesDigestive System DiseasesFemaleHumansIncidenceIranMaleMiddle AgedOpiumProspective StudiesRiskSurvival RateOpium

Identifiers

PMID24145676
PMCPMC5752100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.